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Abstract
Bioassay-guided fractionation is the principal method for the identification of active constituents in medicinal
plants. By design, this method aims to identify the most active compound in a complex mixture with the objective of
discovering novel drug candidates. Described here is a complementary method for the identification of known
bioactive compounds in medicinal plants which is untargeted and which takes advantage of the large NMR database
of known natural products and availability of statistical software. This untargeted bioassay strategy is demonstrated
as a proof of principle in the determination of the antidiabetic compounds in Vitex negundo L. Crude methanol and
ethanol extracts, and chloroform, ethyl acetate and aqueous fractions of V. negundo L. were prepared and tested for
their in vitro antidiabetic potential using the glucose diffusion retardation assay and the in vitro starch-amylase
inhibition assay. The same crude extracts and fractions were profiled using 13C nuclear magnetic resonance (NMR)
spectroscopy. The 13C NMR spectra of twelve known compounds from the semi-polar fraction of V. negundo – two
iridoids, seven iridoid glucosides, two flavonoids and one flavonoid C-glucoside – were matched from the 13C NMR
spectra of the extracts and fractions. The 13C NMR match factor values of the twelve compounds were used in the
multivariate correlation analysis with antidiabetic activity using the glucose diffusion retardation activity and the
starch-amylase inhibition assay. This method was able to correlate the seven iridoid glucosides with the antidiabetic
activity, a result that would have been difficult to obtain using bioassay-guided fractionation.
Keywords: Vitex negundo L.; Untargeted bioassay; Glucose diffusion
retardation index; Alpha-amylase inhibition; Multivariate correlation;
13C NMR profiling; Match factor
Introduction
The standard method for the identification of active compounds in
medicinal plants is bioassay-guided fractionation. This method, which
was first developed in the 1970s has been successfully used for the
discovery of novel bioactive constituents from medicinal plants. By
design, bioassay-guided fractionation is a targeted approach which
aims to identify compounds with strong activity [1]. However, in the
case of medicinal plants that contain several active ingredients with
moderate to low activity which can be additive or synergistic, bioassay-
guided fractionation is not the most efficient strategy. In such cases,
many studies on traditional medicinal plants often end at the level of
solvent or chromatographic fractions and do not proceed further.
Indeed, a number of authors have pointed out this problem and have
suggested that alternative methods be developed [2,3].
Metabolomics refers to the global study of all low molecular weight
metabolites (MW<1,500 Da) in a biological sample, such as a cell,
organ, or a whole organism [4]. The metabolomics approach can be
targeted or untargeted. Targeted metabolomics refers to the
measurement of all known compounds in the sample while untargeted
metabolomics is the comprehensive unbiased profiling of all the
observable compounds in the sample, whether known or unknown.
The ever-expanding database of natural product compounds with
spectroscopic data and the development of metabolomics offer new
approaches in the study of medicinal plants [5]. The most common
techniques used in metabolomics are mass spectrometry (MS) and
nuclear magnetic resonance (NMR) spectroscopy [6]. NMR analysis of
crude extracts yields an unbiased, comprehensive and reproducible
profile of extracts and fractions with minimal sample preparation and
provides structural information from chemical shift data [7]. 1H NMR
is the more common technique used because of its higher sensitivity;
however, 1H spectra are complex because of overlapping multiplets
and are strongly affected by magnetic field strength and solvent. In
comparison, 13C NMR spectra have simpler singlet signals, are
independent of magnetic field strength, and are less affected by solvent
effects making it more reproducible and easier to interpret; however,
13C NMR requires much longer acquisition times [8]. MS, on the other
hand, provides information on molecular masses or fragment masses
and is much more sensitive, but is more useful in a targeted
metabolomics approach [9].
Because untargeted metabolomics generates a lot of data, it must be
coupled to chemometric techniques to reduce the amount of data.
Principal components analysis (PCA) is a useful statistical technique
for reducing the number of variables without loss of information
which enables one to more easily find patterns. PCA clusters data
based on their characteristic similarities and dissimilarities with no
prior knowledge of grouping [10].
An untargeted bioassay strategy using natural product databases
provides an efficient way of profiling and dereplicating medicinal
plants before proceeding to bioassay-guided fractionation to look for
novel compounds. In this work, we illustrate the strategy of untargeted
bioassay for the study of medicinal plants. Briefly, the untargeted
bioassay strategy that is used in this work involves the preparation of
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several non-identical extracts and fractions which are bio assayed and
profiled using 13C NMR. In the case of 13C NMR, the process of
searching for matches between spectra in the database and extracts can
be facilitated using automated systems which are able to compare the
chemical shifts and intensities in the NMR spectra of the extracts with
those from the database to obtain a match which can be scored
according to closeness of fit. A rapid and accurate method for
calculating 13C NMR for use in automated structure elucidation was
proposed using artificial neural networks, this is the method used in
commercial software, such as ACD Labs software Spectrus™. The
results can also be manually evaluated as needed which can reveal
partial structures [11].
The bioassay results and the matched compounds from 13C NMR
spectra are then subjected to multivariate analysis to reveal
correlations between biological activity and matched compounds. This
method may be considered as an initial screen and dereplication prior
to a search for novel compounds using bioassay-guided fractionation.
Diabetes is the third leading cause of death after heart disease and
cancer [12] and medicinal plants can provide a safe and affordable
option for the management of diabetes [13]. Carbohydrate digestion
starts in the mouth by the hydrolyzing enzyme amylase and continues
in the stomach with gastric acid and digestive enzymes. Lower
postprandial glucose can be achieved if the rate of its absorption in the
small intestine can be decreased [14]. This dialysis experiment mimics
the events that occur in the small intestine and is the basis for the in
vitro experiment of glucose retardation that will be used in this study.
The glucose diffusion retardation index (GDRI) is a useful in vitro
method for the determination of the effect of a plant sample on the
delay in glucose diffusion in the gastrointestinal tract. The lower the
GDRI value the greater the inhibition activity of the sample. The
glucose diffusion model is a simple water bath incubation setup that
has been used by many researchers to evaluate the effect of potential
antidiabetic agents before initiating long and costly clinical trials
[15-17].
Vitex negundo L. has been known since ancient times as a medicinal
plant for various ailments [18] and a number of flavonoids and iridoids
have been isolated from its semi-polar fractions (Figure 1) [8,19,20].
Both in vitro and in vivo studies have shown that V. negundo has
promising anti-diabetic properties, in particular, alpha-amylase
inhibitory activity [21], regulation of plasma and tissue glycoprotein
components in streptozotocin-treated rats [22], and antidiabetic
activity using alloxan-treated rats [23]. Devani et al. [24] reported that
the chloroform, ethyl acetate, and n-butanol crude extracts of V.
negundo showed alpha-amylase inhibition. Sundaram et al. [25]
reported the isolation of an iridoid glucoside, 2'-para-hydroxybenzoyl
mussaenosidic acid (4, also known as negundoside), that showed its
antihyperglycemic effect by improving insulin secretion in diabetic
rats. Although the study of Sundaram et al. [25] identified a specific
compound, it is possible that other compounds may also be active.
This study aims to apply the untargeted bioassay strategy using 13C
NMR for the identification of anti-diabetic compounds in V. negundo
using an in vitro glucose diffusion retardation and alpha-amylase
inhibition assays. V. negundo will be separated into crude extracts and
solvent fractions which will be assayed; these will not be subjected to
extensive bioassay-guided fractionation. The results of the assays and
the match factors for each of the twelve V. negundo compounds with
the 13C NMR spectra of the crude extracts and solvent fractions will be
correlated using multivariate methods to determine which compounds
may be active. The results of the untargeted approach will be compared
with previously published work on the anti-diabetic compounds in V.
negundo which used the method of bioassay-guided fractionation.
Experimental
Materials and reagents
The following materials and reagents were used: dialysis membrane
tubing, 1000 Da molecular weight cut-off (MWCO) (Spectra/Por®);
alpha-amylase (400 U/mL, obtained from (University of the
Philippines Los Baños, Laguna); 3,5-dinitrosalicylic acid, 98% (DNS)
(Sigma-Aldrich); dimethyl sulfoxide-D6, 99.9% (Cambridge Isotope
Laboratories, Inc.); and 1,4-dioxane (Merck Darmstadt).
Plant material and extraction
V. negundo leaves were collected from the University of the
Philippines Los Baños, Laguna. The leaves were dried with warm air,
ground with a blender to a coarse powder, and sieved (590 microns,
U.S. Standard Sieve Series). Crude extraction was done by maceration
of the powdered plant (100 g) for 48 hours with 500 mL of 70:30
methanol:water. The solution was filtered and concentrated in vacuo.
The concentrated crude extract was then subjected to liquid-liquid
sequential fractionation using 150 mL of hexane, chloroform, and ethyl
acetate. The hexane fraction was discarded. This gave four samples as
follows: crude methanol (M-cr); methanol-chloroform (M-Chl);
methanol-ethyl acetate (M-Et); and methanol-aqueous (M-aq). The
same procedure was done using 70:30 ethanol:water extraction
mixture, giving another 4 samples: crude ethanol (E-cr); ethanol-
chloroform (E-Chl); ethanol-ethyl acetate (E-Et); and ethanol-aqueous
(E-aq). All the samples were dried under a stream of nitrogen gas and
then freeze dried. A total of 8 samples were used for the bioassay runs
and 13C NMR profiling measurements. The workflow is described in
Figure 2.
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Figure 1: Iridoids and flavonoids that have been identified from the semi-polar fraction of V. negundo.
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Figure 2: Workflow for the fractionation, in vitro assay and 13C NMR profiling. The use of aqueous methanol and aqueous ethanol extraction
solvents is meant to generate variability in the composition of the extracts and fractions. Shaded boxes refer to extracts and fractions that were
subjected to bioassay and 13C NMR profiling.
Determination of glucose concentration
The 3,5-dinitrosalicylic acid (DNS) reagent was used to quantify
glucose in the external solution of the dialysate (Wang, 2015). Glucose
was used as a standard to estimate the reducing sugars present in the
samples using a 96-well microplate reader (BioTek™ Eon™, Gen 2.05
software) at 540 nm. A standard curve was established using the
following glucose concentrations: 0.25, 0.50, 1, 2, 3, 5, 7, 10 and 15
mM.
Retardation of glucose diffusion by plant extracts
The diffusion of free glucose was determined using the method of
Ahmed et al. [26] with some modifications. V. negundo plant extracts
were weighed and dissolved with 200 µL to make 0.1% w/v (1 mg/mL).
Separate 25 mL solutions containing 0, 7, 10 and 15 mM glucose and
plant extract were placed inside the dialysis tubing membrane (11.5 cm
× 38 mm). A membrane with smaller MWCO (1000 Da) was used,
compared with most literature references that used larger cutoff values
(2,000 to 14,000 Da) [27-31]. The test solution was dialyzed against 200
mL of deionized water at 37 degrees Celsius at 100 rpm using a water
bath shaker. The glucose concentration in the external solution was
measured at time intervals (1, 2, 3, 4 and 5 hours) using the DNS
method.
Glucose diffusion retardation index
The glucose diffusion retardation index (GDRI) was calculated
using the following formula:
The higher the GDRI value the greater the inhibition activity of the
sample.
Two negative control runs were performed: the first did not contain
any plant extract; the second did not contain any glucose. Corrections
were made by subtracting the results of the negative control runs from
those of the test runs.
Inhibition of alpha-amylase by plant extract
The study of the inhibition of alpha-amylase by V. negundo plant
extract was adapted from Ou et al. [28] with modifications. To test for
the effect of the plant extracts, 5 mL (50 U/mL) alpha-amylase and
0.1% (w/v) of V. negundo plant extract in DMSO were mixed. Twenty
milliliters of the above starch solution were then added and dialyzed
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against 200 mL of deionized water at 37 degrees Celsius. The glucose
concentration at the external solution was measured at time (1, 2, 3, 4
and 5 hours) using the DNS method. The negative control was
prepared using 300 µL DMSO in place of the plant extract. Glucose
was used for the calibration curve. Corrections were made by
subtracting the results of the negative control runs from those of the
test runs. It should be noted that upon generation of the glucose from
starch hydrolysis, this may be further retarded by intermolecular
binding with compounds from the plant extract.
NMR profiling
The 13C NMR spectra were recorded on a JEOL Lambda 400
spectrometer at 100 MHz. The chemical shifts are reported in ppm (δ)
units downfield from TMS. DMSO-D6 was used as the solvent and 1,4-
dioxane was used as the internal standard (IS). 16.2 µL of 1,4-dioxane
and 10 mL of DMSO-D6 were mixed and then 0.5 mL (~0.6 g) of this
IS solution was added to the samples (100 mg each).
Statistical analysis and data processing
Four readings were gathered from each of the diffusion test
parameters and values were expressed as: mean ± standard deviation
(SD). Differences between the samples and control test were analyzed
using analysis of variance (ANOVA) followed by Tukey's post hoc test
(SPSS version 16.0). Results with p-values less than 0.05 were
considered significantly different. Other statistical analyses were
performed using JMP™ software package.
13C NMR chemical shifts higher than 4% intensity were selected
from each spectrum. ACD Labs Spectrus™ software was used to
determine the presence of the 12 known V. negundo compounds in the
13C NMR spectrum of each sample (extract and fraction).
The generated match factor for each compound, the glucose
diffusion retardation activities, and the starch-amylase inhibition data
(both expressed as GDRI) were loaded as a JMP table. This procedure
correlates the match factors of each compound with the activity data to
determine which compounds are responsible for the activities of the
samples.
Results and Discussion
An untargeted extraction and fractionation method using 70:30
MeOH:water and 70:30 EtOH:water was used to produce eight samples
which were profiled by 13C NMR and subjected to two in vitro
antidiabetic assay methods. The use of two sets of extraction solvents
was meant to generate overlapping variability, which increases the
ability of the method to produce the correlations between the chemical
profile and activity.
Glucose diffusion retardation test
The glucose concentrations in the external solution of all extracts
were significantly different with the control for all runs (p<0.001) at 7
mM glucose concentration. The trendlines for the GDRI values of the
glucose diffusion retardation tests with glucose concentrations of
7mM, 10mM, and 15mM with 0.1% V. negundo extract are shown in
Figure 3. The following overall observations can be made:
Although a direct comparison between the 1000 MWCO and larger
pore dialysis membranes was not done, our results indicate that this
smaller pore size is able to give good results and is presumably more
selective than membranes with larger pore sizes.
The GDRI values for all extracts were higher during the first hour
and dropped to lower values at 4 hours. This indicates that the
interaction is reversible and approaches equilibrium over time [28].
The GDRI activity was higher at 7mM glucose concentration and
tended towards lower values as the glucose concentration increased.
Since the GDRI is a test for the extent of intermolecular binding of
glucose with compounds in the plant extract, this result is consistent
with the saturable nature of this activity.
The E-Chl and M-Chl showed the highest activity in the GDRI test.
This means that the compounds with strongest glucose binding activity
are found in these fractions.
Figure 3: Trendlines for glucose diffusion retardation test using
0.1% V. negundo extract and glucose concentrations of: (a) 7mM;
(b) 10mM; and (c) 15mM.
Starch-alpha-amylase inhibition test
This test sought to determine the effect of 0.1% V. negundo extract
on the activity of alpha-amylase for starch hydrolysis. The trendlines
for the starch-amylase inhibition tests are shown in Figure 4. The
glucose concentrations in the external solution with extracts during the
first two hours versus control was observed to have a significant
difference with control (p<0.001). The following overall observations
can be made:
• The amylase inhibition values for all extracts were higher during
the first hour and dropped to lower values at 4 hours. This indicates
that enzyme inhibition is reversible.
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• The crude ethanol (E-cr) showed the highest retardation activity,
followed by the ethanol-EtOAc (E-Et) and methanol-chloroform (M-
Chf) fractions.
13C NMR profiles of extracts
Figures 5-7 show the 13C NMR spectra of the various freeze-dried
fractions in DMSO-D6 NMR solvent. A measured amount of internal
standard (1,4-dioxane) was added to all of the NMR samples which
allows for quantitative comparison of peak intensities in the spectra of
all the samples. Although the 13C NMR spectra of the corresponding
methanol and ethanol fractions look similar, their peak intensities vary,
indicating that their constituents differ in amount. These subtle
differences are the basis for the variations that this method is intended
to generate.
Figure 4: Trendlines for starch-alpha amylase inhibition test using
0.1% V. negundo extract concentration.
Figure 5: 13C NMR spectra of: (a) M-Et; and (b) E-Et (NMR solvent:
DMSO-D6; IS: 1,4-dioxane).
Figure 6: 13C NMR spectra of: (a) M-Chf; and (b) E-Chf (NMR
solvent: DMSO-D6; IS: 1,4-dioxane).
Figure 7: 13C NMR spectra of: (a) M-aq; and (b) E-aq (NMR
solvent: DMSO-D6; IS: 1,4-dioxane).
Principal Components Analysis (PCA)
PCA reduces the variables in the results of the glucose diffusion
retardation experiments, the starch-amylase inhibition experiments at
0.1% V. negundo extract concentration, and the 13C NMR spectra of
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the fractions. Figure 8 shows the PCA of data from glucose diffusion
retardation activities at 0.1 % V. negundo extract concentration which
shows that fractions M-Chl, E-aq, and E-Chl cluster on the positive
side of the PC1 axis indicating a strong influence on the activity. The
aqueous-methanol residual fraction (7) appears as an outlier in terms
of its GDRI activity. This PCA accounts for about 80% of variability
which indicates that it is a good model for the GDRI activity.
Figure 8: PCA of glucose diffusion retardation index (GDRI) using
0.1% V. negundo extracts and fractions. Sample 7 (M-aq) is a
possible outlier.
Figure 9 shows the PCA of the starch-amylase inhibition activity.
The spread of the data shows less distinct groupings, which may
suggest that the differences among the activities of the fractions is not
that large. This PCA accounts for about 92% of the variability which
indicates that it is a good model for the starch-amylase inhibition
activity.
Figure 9: PCA of starch-amylase inhibition data using 0.1% V.
negundo extracts and fractions.
Figure 10 shows the PCA of the 13C NMR spectra of the various
plant fractions. This PCA shows three distinct groupings which are
consistent with the solvents used: (M-Chl and E-Chl), (M-Et and E-
Et), and (M-cr, E-cr, M-aq, and E-aq). This PCA accounts for about
77% of the variability which indicates that it is a good model for the
13C NMR spectra.
Figure 10: PCA of 13C NMR of V. negundo extracts and fractions.
The same solvent fractions grouped together.
13C NMR compound identification using match factors
The 13C NMR of the extracts were analyzed using ACD Labs
Spectrus™ software to obtain matches with the 12 known iridoids and
flavonoids from the semi-polar fraction of V. negundo. This software
calculates the 13C NMR spectrum of the compound structure being
matched using a neural model and a library of 13C NMR spectra and
generates a match factor for each compound which depends on
whether all 13C peaks of a compound are found and what the closeness
of these peaks are to the predicted spectrum. A match factor of >0.75 is
considered as a positive match [32].
Table 1 gives the values of the match factors which were generated
using ACD Labs SpectrusTM for the 12 compounds in each of the
fractions. Match factors >0.75 (shown in black color) are considered as
present in the fraction. The calculated match factors indicate that the
iridoid glucosides are present in most of the semi-polar fractions, with
the chloroform fractions (M-Chl and E-Chl) showing the highest
match factors. Among the iridoids, negundoside (4), 6”-p-
hydroxybenzoyl mussaenosidic acid (5), and agnuside (6) were present
in all of the fractions.
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No
Compounds Match Factors for Samples
Name M-cr E-cr M-Et E-Et M-Chi E-Chi M-aq E-aq
1 Nishindaside 0.87 0.88 0.84 0.84 0.90 0.92 0.54 0.81
2 Isonishindaside 0.87 0.89 0.85 0.85 0.91 0.93 0.55 0.81
3 Mussaenosidic acid 0.86 0.86 0.92 0.92 0.92 0.88 0.79 0.87
4 Negundoside 0.89 0.89 0.94 0.94 0.96 0.92 0.81 0.88
5 6"-p-hydroxybenzoyl mussaenosidic acide 0.88 0.88 0.87 0.91 0.94 0.91 0.82 0.88
6 Agnuside 0.91 0.91 0.83 0.86 0.96 0.94 0.82 0.84
7 Aucubin 0.88 0.92 0.73 0.92 0.95 0.93 0.67 0.84
8 8-epi loganic acid 0.92 0.9 0.45 0.90 0.97 0.97 0.28 0.73
9 Lagundinin 0.85 0.85 0.3 0.85 0.90 0.97 0.14 0.30
10 Luteolin 0.24 0.25 0.94 0.94 0.73 0.64 0.91 0.24
11 Casticin 0.06 0.24 0.42 0.57 0.98 0.95 0.26 0.15
12 Isoorientin 0.22 0.33 0.93 0.97 0.78 0.77 0.95 0.28
Table 1: Match factors generated using ACD Labs SpectrusTM based on the 13C NMR for the twelve compounds in each of the fractions. Match
factors >0.75 (shown in black color) are considered as present in the fraction.
Multivariate correlations of GDRI activity with identified
compounds
Table 2 gives the values of the multivariate correlations for the
GDRI test for each of the 12 compounds at the 1st and 4th hour for
glucose at 7, 10, and 15 mM concentration. The correlation values
suggest the following: 1. The GDRI activities of the iridoid glucosides
are higher than the flavonoids; 2. The activity is highest at 7mM
glucose concentration. This is consistent with saturation of activity at
higher glucose concentrations; and 3. The activity is highest at the first
hour and falls over time. This is consistent with Figure 3 and suggests
tendency towards equilibrium condition. The following glucosylated
iridoids showed highest activities in the GDRI test: mussaenosidic acid
(3), negundoside (4), and 6”-p-hydroxybenzoyl mussaenosidic acid
(5). On the other hand, the non-glucosylated iridoid, lagundinin (9),
and the flavonoids (10-12) gave low correlation values. It is of interest
to note that negundoside (4), which was previously identified as an
antidiabetic compound (Sundaram et al.), was also identified as active
in the GDRI test.
No.
Compounds
Multivariate Correlations
7mM glucose 10mM glucose 15mM glucose
Name 1 hr 4 hr 1 hr 4 hr 1 hr 4 hr
1 Nishindaside 0.70 0.26 0.48 0.35 0.60 0.03
2 Isonishindaside 0.71 0.26 0.45 0.36 0.60 0.03
3 Mussaenosidic acid 0.84 0.39 0.17 0.60 0.52 0.33
4 Negundoside 0.85 0.42 0.23 0.63 0.54 0.27
5 6"-p-hydroxybenzoyl mussaenosidic acide 0.85 0.51 0.37 0.67 0.49 0.30
6 Agnuside 0.61 0.33 0.47 0.37 0.49 -0.03
7 Aucubin 0.68 0.21 0.36 0.37 0.56 -0.06
8 8-epi loganic acid 0.68 0.21 0.44 0.34 0.60 -0.03
9 Lagundinin 0.53 0.51 0.55 0.66 0.27 0.19
10 Luteolin -0.21 0.14 -0.45 0.38 -0.49 0.06
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11 Casticin 0.45 0.66 0.18 0.85 -0.11 0.26
12 Isoorientin -0.21 0.19 0.43 0.44 -0.54 0.03
Table 2: Multivariate correlations for the GDRI test for each of the 12 compounds at the 1st and 4th hour for glucose at 7, 10, and 15 mM
concentration at 0.1% V. negundo concentration.
Multivariate correlations of starch-alpha-amylase activity
with identified compounds
Table 3 gives the multivariate correlations for the starch-amylase
inhibition test for each of the 12 compounds at the 1st and 4th hour at
0.1% V. negundo concentration. The correlation values suggest the
following: 1. The activities of the iridoid glucosides are higher than the
flavonoids; and 2. The activity is highest at the first hour and falls to
equilibrium values at the 4th hour consistent with Figure 4. In this test,
agnuside (6) showed the highest activity, followed by the other
glucosylated iridoids, including negundoside (4). The flavonoids
(10-12) gave low correlation values in this test.
No.
Compounds
Multivariate Correlations
Alpha-amylase
Name 1 hr 4 hr
1 Nishindaside 0.67 -0.23
2 Isonishindaside 0.67 -0.21
3 Mussaenosidic acid 0.41 -0.07
4 Negundoside 0.55 -0.06
5 6"-p-hydroxybenzoyl mussaenosidic acide 0.64 -0.16
6 Agnuside 0.88 -0.10
7 Aucubin 0.66 -0.07
8 8-epi loganic acid 0.67 -0.16
9 Lagundinin 0.48 -0.36
10 Luteolin -0.39 -0.32
11 Casticin 0.39 -0.05
12 Isoorientin -0.36 0.32
Table 3: Multivariate correlations for the starch-alpha-amylase
inhibition test for each of the 12 compounds at the 1st and 4th hour at
0.1% V. negundo concentration.
Conclusions
The present study provides in vitro confirmation of the potential of
V. negundo as a hypoglycemic agent. The crude extracts and the
fractions of V. negundo were prepared via untargeted extraction which
had the objective of increasing variability among the samples to be
tested. The extracts were evaluated using an in vitro model for the
retardation of the diffusion of glucose across the intestinal membrane
into the bloodstream and the inhibition of amylase activity on starch.
The methanol-chloroform and ethanol-chloroform fractions showed
the highest activity in retarding glucose diffusion while the crude
methanol extract and methanol-chloroform fraction showed highest
starch-amylase inhibition. Correlation analysis of the match factors of
the twelve known V. negundo compounds from the 13C NMR profiles
of the samples with activities suggests that iridoid glucosides may be
responsible for the glucose retardation activity and starch-amylase
inhibition activity. Our work indicates that the iridoid glucosides, in
particular, negundoside (4), 6’-para-hydroxybenzyolmussaenosidic
acid (5), agnuside (6), aucubin (7), and 8-epi-loganic acid (8), have
anti-diabetic activity. Negundoside (4), which was previously identified
as an anti-diabetic compound, was also identified in this study. Thus,
this work serves as a proof of principle that this is a viable and valid
method.
This work can be extended in a number of ways. Other known
compounds from the plant can be added to determine whether these
can be matched to the spectra and activity of the fractions. The
identified compounds can be quantified, and further studies can be
conducted to determine whether the activity is additive or synergistic.
If the compound is present at low quantities, further fractionation can
be done.
This work demonstrates that if a biological activity is due to known
compounds, an untargeted approach using 13C NMR profiling
combined the appropriate assay can be used as a first step. This method
takes advantage of NMR spectral software and PCA to assist in the
identification of known active compounds. However, bioassay-guided
fractionation will be required in cases where the activity is due to a
novel compound.
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